BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34896652)

  • 1. An updated review of anti-Ro52 (TRIM21) antibodies impact in connective tissue diseases clinical management.
    Decker P; Moulinet T; Pontille F; Cravat M; De Carvalho Bittencourt M; Jaussaud R
    Autoimmun Rev; 2022 Mar; 21(3):103013. PubMed ID: 34896652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical associations of the positive anti Ro52 without Ro60 autoantibodies: undifferentiated connective tissue diseases.
    Murng SHK; Thomas M
    J Clin Pathol; 2018 Jan; 71(1):12-19. PubMed ID: 28663326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Utility of Separate Anti-Ro60 and Anti-Ro52/TRIM21 Antibody Detection in Autoimmune Diseases.
    Robbins A; Hentzien M; Toquet S; Didier K; Servettaz A; Pham BN; Giusti D
    Front Immunol; 2019; 10():444. PubMed ID: 30915082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ro52/TRIM21 - From host defense to autoimmunity.
    Holwek E; Opinc-Rosiak A; Sarnik J; Makowska J
    Cell Immunol; 2023; 393-394():104776. PubMed ID: 37857191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Ro52/TRIM21 antibodies are associated with aberrant inflammatory circuits in patients with systemic autoimmune rheumatic diseases.
    Amezcua-Guerra LM; Pérez-García LF; Jiménez-Rojas V; Márquez-Velasco R; Silveira LH
    Gac Med Mex; 2023; 159(1):55-64. PubMed ID: 36930561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Ro52 Autoantibody Is Common in Systemic Autoimmune Rheumatic Diseases and Correlating with Worse Outcome when Associated with interstitial lung disease in Systemic Sclerosis and Autoimmune Myositis.
    Chan EKL
    Clin Rev Allergy Immunol; 2022 Oct; 63(2):178-193. PubMed ID: 35040083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New coupled-particle light-scattering assay for detection of Ro/SSA (52 and 60 kilodaltons) and La/SSB autoantibodies in connective tissue diseases.
    Bizzaro N; Bonelli F; Tonutti E; Tozzoli R; Villalta D
    Clin Diagn Lab Immunol; 2001 Sep; 8(5):922-5. PubMed ID: 11527804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical associations of anti-SSA/Ro60 and anti-Ro52/TRIM21 antibodies: Diagnostic utility of their separate detection.
    Menéndez A; Gómez J; Escanlar E; Caminal-Montero L; Mozo L
    Autoimmunity; 2013 Feb; 46(1):32-9. PubMed ID: 23039326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Combined Anti-Ro52/TRIM21 and Anti-Ro60/SSA Antibodies With Increased Sjögren Disease Severity Through Interferon Pathway Activation.
    Bettacchioli E; Saraux A; Tison A; Cornec D; Dueymes M; Foulquier N; Hillion S; Roguedas-Contios AM; Benyoussef AA; Alarcon-Riquelme ME; Pers JO; Devauchelle-Pensec V;
    Arthritis Rheumatol; 2024 May; 76(5):751-762. PubMed ID: 38130019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective analysis of the clinical significance of Ro52/TRIM21 antibody and specific antinuclear antibody patterns by indirect immunofluorescence.
    Liu K; Liao Y; Li P; Shi J
    J Pak Med Assoc; 2024 Feb; 74(2):236-242. PubMed ID: 38419219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: results of a multicentric study.
    Ghillani P; André C; Toly C; Rouquette AM; Bengoufa D; Nicaise P; Goulvestre C; Gleizes A; Dragon-Durey MA; Alyanakian MA; Chretien P; Chollet-Martin S; Musset L; Weill B; Johanet C
    Autoimmun Rev; 2011 Jul; 10(9):509-13. PubMed ID: 21447407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the role and clinical utility of anti-Ro52/TRIM21 in systemic autoimmunity.
    Lee AYS
    Rheumatol Int; 2017 Aug; 37(8):1323-1333. PubMed ID: 28417151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Ro52 and/or anti-Ro60 immune reactivity: autoantibody and disease associations.
    Zampeli E; Mavrommati M; Moutsopoulos HM; Skopouli FN
    Clin Exp Rheumatol; 2020; 38 Suppl 126(4):134-141. PubMed ID: 32083547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of anti-Ro52 (TRIM21) antibodies in adult patients with connective tissue diseases.
    Decker P; Moulinet T; Lopez B; Dubucquoi S; Bonnotte B; Lakomy D; Revuz S; Luc A; Bittencourt MC; Hachulla E; Jaussaud R
    Eur J Intern Med; 2021 Sep; 91():45-52. PubMed ID: 33972152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis.
    Hudson M; Pope J; Mahler M; Tatibouet S; Steele R; Baron M; ; Fritzler MJ
    Arthritis Res Ther; 2012 Mar; 14(2):R50. PubMed ID: 22394602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Ro52/TRIM21 serological subsets identify differential clinical and laboratory parameters.
    Lee AYS; Lin MW; Reed JH
    Clin Rheumatol; 2022 Nov; 41(11):3495-3501. PubMed ID: 35871174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Sjögren's syndrome-associated autoantigen Ro52/TRIM21 modulates follicular B cell homeostasis and immunoglobulin production.
    Brauner S; Ivanchenko M; Thorlacius GE; Ambrosi A; Wahren-Herlenius M
    Clin Exp Immunol; 2018 Dec; 194(3):315-326. PubMed ID: 30178506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fine specificity of the Ro/SSA autoantibody response in relation to serological and clinical findings in 96 patients with self-reported cutaneous symptoms induced by the sun.
    Popovic K; Brauner S; Ek M; Wahren-Herlenius M; Nyberg F
    Lupus; 2007; 16(1):10-7. PubMed ID: 17283579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Significance of Different Profiles of anti-Ro Antibodies in Connective Tissue Diseases.
    Yang HT; Hong XP; Guo JW; Zhong XL; Liao R; Liu CL; Liu LX; Li K; Chen YL; Liu DZ
    J Immunol Res; 2023; 2023():9195157. PubMed ID: 36741231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common and specific associations of anti-SSA/Ro60 and anti-Ro52/TRIM21 antibodies in systemic lupus erythematosus.
    Menéndez A; Gómez J; Caminal-Montero L; Díaz-López JB; Cabezas-Rodríguez I; Mozo L
    ScientificWorldJournal; 2013; 2013():832789. PubMed ID: 24294139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.